Clinical Trial Update: Arginine Treatment of Acute Chest Syndrome (Pneumonia) in Sickle Cell Disease Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating L-arginine for acute chest syndrome in sickle cell disease patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chest Syndrome
• Pneumonia
• Sickle Cell Disease

Drugs mentioned

• L-Arginine (L-Arginine)

Snippet

Sponsor: UCSF Benioff Children's Hospital Oakland | Conditions: Anemia, Sickle Cell, Pneumonia | Phase 2 | Status: COMPLETED